A Mediterranean Diet in for Colon Cancer Prevention
地中海饮食有助于预防结肠癌
基本信息
- 批准号:8004091
- 负责人:
- 金额:$ 28.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-01-01 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdherenceAmericanAnimalsAnti-Inflammatory AgentsAnti-inflammatoryBiological MarkersBiopsyBloodBlood specimenCanned FoodsCarotenoidsCellsChemopreventive AgentColon CarcinomaColorectalColorectal CancerComputer-Assisted Image AnalysisConflict (Psychology)DataDetectionDietDietary FatsDietary InterventionDietary PracticesDietary intakeDinoprostoneDiseaseEatingEicosanoid ProductionEicosanoidsEpidemiologyEpithelialEpithelial Cell ProliferationEpithelial CellsExperimental ModelsFat red 7B stainFatty AcidsFiberFlexible fiberoptic sigmoidoscopyFoodHealthHealthy People 2010HumanHydroxyeicosatetraenoic AcidsInflammationInflammation MediatorsIntakeInterventionLabelLeukotriene B4LeukotrienesLipoxygenaseLiquid substanceMeatMediator of activation proteinMediterranean DietMethodsMilkMonounsaturated Fatty AcidsMucous MembraneNuclearNutrientOlives - dietaryParticipantPersonsPharmacologic SubstancePhytochemicalPlantsPolyunsaturated Fatty AcidsPotatoPrevention approachPreventiveProcessProstaglandin-Endoperoxide SynthaseProstaglandinsProtocols documentationRandomizedRecruitment ActivityRelative (related person)Research PersonnelRiskRoleSerumSupplementationTestingTissuesarmbasebeefcancer preventioncancer riskcarcinogenesiscolorectal cancer preventiondesigneicosanoid metabolismfruits and vegetablesimprovedmonounsaturated fatmorphometrynovelpolyunsaturated fatpressureprogramsprospectiveprostaglandin E3stemtumorigenesis
项目摘要
DESCRIPTION (provided by applicant): A Mediterranean Diet for Colon Cancer Prevention: Epidemiological and animal studies indicate that the major components of the traditional Cretan-Mediterranean diet have great promise for the prevention of colorectal cancer while improving overall health. Relative to the American diet, the Mediterranean diet is lower in n-6 fatty acids, polyunsaturated fats, and red meat while intakes of plant-based foods and monounsaturated fats are higher. The hypothesis behind this proposal is that adherence to a Mediterranean type of diet will result in a decrease in n-6 fatty acids and increased n-3 and n-9 fatty acids in human colonic mucosa. This, together with other aspects of the diet such as increased intakes of phytochemicals in fruits and vegetables, is expected to modulate eicosanoid metabolism in normal colorectal mucosa to its anticarcinogenic state resulting in lower colonic proliferation. We will recruit 120 study participants who are at increased risk of colorectal cancer. Subjects will be randomized to a modified Mediterranean diet or a Healthy People 2010 diet for 6 months. The Mediterranean diet will be designed to decrease polyunsaturated fat intake and to increase intakes of monounsaturated fats, fruits and vegetables. These dietary changes are expected to not only decrease pro-inflammatory mediators and increase anti-inflammatory mediators, but to also change the types of eicosanoids that are produced from cyclooxygenases and lipoxygenases. Our pilot testing of this novel exchange list diet indicates that subjects can make very large dietary changes. Dietary intake data, blood samples and biopsies of normal mucosa from flexible sigmoidoscopy will be analyzed before and after intervention, and changes from baseline will be compared in the 2 diet arms. The specific endpoints are fatty acids and carotenoids in blood and mucosa, the types and levels of inflammatory mediators in the mucosa, and proliferation in the mucosa. We expect that the Healthy People 2010 diet will result in minimal changes relative to the Mediterranean diet. Increasing our understanding of the effects of dietary changes on human mucosa is fundamental to evaluating the potential of diet in colorectal cancer prevention. Such data would also validate the use of these biomarkers as screen for other dietary and/or pharmaceutical-based interventions aimed at slowing or reversing carcinogenesis. If beneficial effects can be demonstrated in mucosal biomarkers of colorectal cancer risk (prostaglandin E2, other eicosanoids, proliferation), such data may be used to justify a larger, prospective intervention with disease endpoints and more detailed dietary studies.
描述(由申请人提供):预防结肠癌的地中海饮食:流行病学和动物研究表明,传统克里特岛-地中海饮食的主要成分对于预防结直肠癌同时改善整体健康有很大希望。相对于美国饮食,地中海饮食的 n-6 脂肪酸、多不饱和脂肪和红肉含量较低,而植物性食物和单不饱和脂肪的摄入量较高。该提议背后的假设是,坚持地中海式饮食将导致人类结肠粘膜中 n-6 脂肪酸减少,n-3 和 n-9 脂肪酸增加。这与饮食的其他方面(例如增加水果和蔬菜中植物化学物质的摄入量)一起,预计可以将正常结直肠粘膜中的类二十烷酸代谢调节至其抗癌状态,从而降低结肠增殖。我们将招募 120 名罹患结直肠癌风险较高的研究参与者。受试者将被随机分配接受改良地中海饮食或 Healthy People 2010 饮食,为期 6 个月。地中海饮食旨在减少多不饱和脂肪的摄入量并增加单不饱和脂肪、水果和蔬菜的摄入量。这些饮食变化预计不仅会减少促炎介质并增加抗炎介质,还会改变由环氧合酶和脂氧合酶产生的类二十烷酸的类型。我们对这种新颖的交换清单饮食的初步测试表明,受试者可以做出非常大的饮食改变。将在干预前后分析饮食摄入数据、血液样本和柔性乙状结肠镜检查的正常粘膜活检,并比较两个饮食组相对于基线的变化。具体终点是血液和粘膜中的脂肪酸和类胡萝卜素、粘膜中炎症介质的类型和水平以及粘膜中的增殖。我们预计 2010 年健康人饮食相对于地中海饮食将产生最小的变化。增加我们对饮食变化对人类粘膜影响的了解对于评估饮食在结直肠癌预防中的潜力至关重要。这些数据还将验证这些生物标志物作为其他旨在减缓或逆转致癌作用的基于饮食和/或药物的干预措施的筛选的用途。如果可以在结直肠癌风险的粘膜生物标志物(前列腺素 E2、其他类二十烷酸、增殖)中证明有益效果,则此类数据可用于证明对疾病终点和更详细的饮食研究进行更大规模、前瞻性干预的合理性。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Precision in donor selection: Identifying ideal stem-cell donors through their T cells.
捐赠者选择的精确性:通过 T 细胞识别理想的干细胞捐赠者。
- DOI:10.1016/j.exphem.2016.07.013
- 发表时间:2016
- 期刊:
- 影响因子:2.6
- 作者:Widman,Adam;Reshef,Ran
- 通讯作者:Reshef,Ran
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zora Djuric其他文献
Zora Djuric的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zora Djuric', 18)}}的其他基金
A Mediterranean Diet in for Colon Cancer Prevention
地中海饮食有助于预防结肠癌
- 批准号:
7327791 - 财政年份:2007
- 资助金额:
$ 28.78万 - 项目类别:
A Mediterranean Diet in for Colon Cancer Prevention
地中海饮食有助于预防结肠癌
- 批准号:
7559540 - 财政年份:2007
- 资助金额:
$ 28.78万 - 项目类别:
A Mediterranean Diet in for Colon Cancer Prevention
地中海饮食有助于预防结肠癌
- 批准号:
7210954 - 财政年份:2007
- 资助金额:
$ 28.78万 - 项目类别:
A Mediterranean Diet in for Colon Cancer Prevention
地中海饮食有助于预防结肠癌
- 批准号:
7754455 - 财政年份:2007
- 资助金额:
$ 28.78万 - 项目类别:
A Mediterranean Diet in for Colon Cancer Prevention
地中海饮食有助于预防结肠癌
- 批准号:
7846930 - 财政年份:2007
- 资助金额:
$ 28.78万 - 项目类别:
LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (LC-MS)
液相色谱-质谱联用仪 (LC-MS)
- 批准号:
2791796 - 财政年份:1999
- 资助金额:
$ 28.78万 - 项目类别:
相似国自然基金
基于保护动机理论的新确诊青少年HIV感染者抗病毒治疗依从性“游戏+”健康教育及作用机制研究
- 批准号:82304256
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于前景理论的ADHD用药决策过程与用药依从性内在机制研究
- 批准号:72304279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于强化学习AI聊天机器人对MSM开展PrEP服药依从性精准干预模式探索及干预效果研究
- 批准号:82373638
- 批准年份:2023
- 资助金额:59 万元
- 项目类别:面上项目
基于HAPA理论的PCI术后患者运动依从性驱动机制与干预方案构建研究
- 批准号:72304180
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CAS理论视角下农村老年心血管代谢性共病管理依从性的社区-患者协同机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Dietary prevention for colorectal cancer: targeting the bile acid/gut microbiome axis
结直肠癌的饮食预防:针对胆汁酸/肠道微生物组轴
- 批准号:
10723195 - 财政年份:2023
- 资助金额:
$ 28.78万 - 项目类别:
A Diet Intervention Study To Mitigate Fatigue Symptoms And To Improve Muscle And Physical Function In Older Adults With Post-Acute COVID-19 Syndrome
一项饮食干预研究,旨在减轻患有急性后 COVID-19 综合症的老年人的疲劳症状并改善肌肉和身体功能
- 批准号:
10734981 - 财政年份:2023
- 资助金额:
$ 28.78万 - 项目类别:
Long acting biodegradable buprenorphine depots
长效可生物降解丁丙诺啡储库
- 批准号:
10757180 - 财政年份:2023
- 资助金额:
$ 28.78万 - 项目类别:
Developing, Refining, and Testing a Mobile Health Question Prompt List in Gastroesophageal Reflux Disease
开发、完善和测试胃食管反流病移动健康问题提示表
- 批准号:
10739903 - 财政年份:2023
- 资助金额:
$ 28.78万 - 项目类别:
Plant-Focused Nutrition in Patients with Diabetes and Chronic Kidney Disease (PLAFOND Study): A Pilot/Feasibility Study
糖尿病和慢性肾病患者的植物性营养(PLAFOND 研究):试点/可行性研究
- 批准号:
10586677 - 财政年份:2023
- 资助金额:
$ 28.78万 - 项目类别: